Tonghua Dongbao Pharmaceutical Co., Ltd. Class ASSE: 600867

(600867)"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Pledge Release and Re-pledge of Shares Held by the Controlling Shareholder

Sep 29, 2026 · Issued by Tonghua Dongbao Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE · Stock code 600867 · Sep 29, 2026

Announcement on Pledge Release and Re-pledge of Shares Held by the Controlling Shareholder

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

View original source (Shanghai Stock Exchange)Company analysis

Earlier from Tonghua Dongbao Pharmaceutical Co., Ltd. Class A

"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Allocation of Reserved Portion under Employee Stock Ownership Plan for R&D and Production SystemSep 1
"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Termination of an R&D Project and Provision for Asset ImpairmentAug 25
"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Results of Exercising the Preemptive Rights to Subscribe for the Convertible Corporate Bonds Issued to Unspecified Investors by Xiamen Amoytop Biotech Co., Ltd.Aug 12
"Tonghua Dongbao Pharmaceutical Co., Ltd."Announcement on Release of Pledge and Re-pledge of Controlling Shareholder's SharesJul 29

All Tonghua Dongbao Pharmaceutical Co., Ltd. Class A news releases